US 10508122
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
granted A61PA61P25/00A61P35/00
Quick answer
US patent 10508122 (Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P35/00, A61P37/00, A61P37/02